See the Full Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Leo XIV
Pope Francis
Mother's Day
Vatican
Artificial Intelligence
Catholic Church
World War II
Parade
Social Media
Vladimir Putin
European Union
Stock Markets
Published • loading... • Updated

Plaintiff Sues Eli Lilly, Johnson & Johnson Over Alleged Breast Cancer Risk Linked To Antipsychotic Medications - Eli Lilly (NYSE:LLY)

Summary by Benzinga
A lawsuit claims Eli Lilly, Johnson & Johnson, and Kaiser Permanente failed to warn consumers about breast cancer risks linked to their antipsychotic drugs Risperdal and Zyprexa.

1 Articles

All
Left
Center
1
Right
BenzingaBenzinga
Center

Plaintiff Sues Eli Lilly, Johnson & Johnson Over Alleged Breast Cancer Risk Linked To Antipsychotic Medications - Eli Lilly (NYSE:LLY)

A lawsuit claims Eli Lilly, Johnson & Johnson, and Kaiser Permanente failed to warn consumers about breast cancer risks linked to their antipsychotic drugs Risperdal and Zyprexa.

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Monday, April 28, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Eli Lilly

Eli Lilly

United States

United States

News
For You
SearchBlindspotLocal